BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38817215)

  • 1. Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report.
    Chen Y; Kong BB; Yin H; Liu H; Wu S; Xu T
    World J Clin Cases; 2024 May; 12(15):2621-2626. PubMed ID: 38817215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature.
    Macías I
    Int J Surg Case Rep; 2016; 28():93-96. PubMed ID: 27693837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.
    Dias E; Liberal R; Costa-Moreira P; Príncipe F; Fonseca E; Macedo G
    GE Port J Gastroenterol; 2022 Mar; 29(2):125-131. PubMed ID: 35497670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.
    Colaizzo D; Amitrano L; Tiscia GL; Scenna G; Grandone E; Guardascione MA; Brancaccio V; Margaglione M
    J Thromb Haemost; 2007 Jan; 5(1):55-61. PubMed ID: 17059429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique case of bleeding from esophageal varices as the first sign of essential thrombocythemia.
    Brito M; Nunes G; Laranjo A; Sabino J; Oliveira C; Valle S; Gonçalves D; Fonseca J
    Clin J Gastroenterol; 2021 Dec; 14(6):1612-1616. PubMed ID: 34342841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal variceal bleeding: portal hypertension and portal vein thrombosis secondary to protein S deficiency - a case report.
    Sapkota P; Mainali S; Khadayat P; K C N; Joshi A; Koirala P
    Ann Med Surg (Lond); 2023 Sep; 85(9):4597-4602. PubMed ID: 37663703
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Rao R; Grosel J
    Radiol Case Rep; 2018 Dec; 13(6):1249-1255. PubMed ID: 30258517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy.
    Wanless IR; Peterson P; Das A; Boitnott JK; Moore GW; Bernier V
    Hepatology; 1990 Nov; 12(5):1166-74. PubMed ID: 2227815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
    Giszas B; Weber M; Heidel FH; Reuken PA
    Dig Dis; 2022; 40(4):530-534. PubMed ID: 34348280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia.
    Dos Santos LC; Ribeiro JC; Silva NP; Cerutti J; da Silva MR; Chauffaille Mde L
    Rev Bras Hematol Hemoter; 2011; 33(6):417-24. PubMed ID: 23049357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus Kinase V617F Mutation Detection in Patients with Myelofibrosis.
    Nikolova D; Yordanov A; Damyanova V; Radinov A; Toncheva D
    Balkan J Med Genet; 2019 Jun; 22(1):57-60. PubMed ID: 31523621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.
    Payzin KB; Savasoglu K; Alacacioglu I; Ozdemirkiran F; Mutlu BB; Bener S; Calli AO; Kucukzeybek BB; Aksun S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):525-33. PubMed ID: 24811089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis.
    Link CS; Platzbecker U; Kroschinsky F; Pannach S; Thiede C; Platzek I; Ehninger G; Schuler MK
    Case Rep Oncol; 2013 May; 6(2):311-5. PubMed ID: 23898274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.
    De Stefano V; Fiorini A; Rossi E; Za T; Farina G; Chiusolo P; Sica S; Leone G
    J Thromb Haemost; 2007 Apr; 5(4):708-14. PubMed ID: 17263783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of portal vein thrombosis on the efficacy of endoscopic treatment in preventing re-bleeding from ruptured gastroesophageal varices in hepatitis B-related liver cirrhosis].
    Huang XQ; Ni LY; Jiang SY; Xia RQ; Ma LL; Wang J; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):747-752. PubMed ID: 33053974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.